Flamingo Therapeutics (SA)
Active
VAT
BE 0729.892.237
Address
Gaston Geenslaan 3
3001
Leuven
Established
08-07-2019
Principal activity
Research and experimental development on biotechnology
Crisis resilience of Flamingo Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of Flamingo Therapeutics
2023
|
2022
|
2021
|
2020
|
||||
|---|---|---|---|---|---|---|---|
| Profit/Loss | -€10,808,085 | -47% |
-€7,341,353 | -204% |
-€2,417,249 | -112% |
-€1,142,597 |
| Equity | €37,621,172 | > 1.000% |
-€3,092,196 | -173% |
€4,247,056 | 46% |
€2,914,304 |
| Gross margin | -€1,308,508 | < -1.000% |
€125,311 | -43% |
€221,700 | 134% |
-€656,863 |
| Employees | 15,1 FTE | 84% |
8,2 FTE | 46% |
5,6 FTE | 87% |
3 FTE |
Publications in the Belgian Official Journal for Flamingo Therapeutics
Frequently asked questions
What is the VAT number of Flamingo Therapeutics?
The VAT number of Flamingo Therapeutics is BE0729892237.
When was Flamingo Therapeutics founded?
Flamingo Therapeutics was founded on 08-07-2019.
What is the address of Flamingo Therapeutics?
The current registered office of Flamingo Therapeutics is located at Gaston Geenslaan 3, 3001 Leuven.
When was the last time Flamingo Therapeutics filed their annual financial statements?
The most recent financial statements of Flamingo Therapeutics were filed on 12-07-2024. You can view them here.
How many employees does Flamingo Therapeutics have?
There are 15,1 FTEs working at Flamingo Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Flamingo Therapeutics?
At the time of its most recent financial statements, Flamingo Therapeutics did not publish any turnover figures. Flamingo Therapeutics reported a gross margin of -€1,308,507.75.
